Non ci sono recensioni
|
||||||||||
|
||||||||||
|
Table of Contents:
SECTION I: EPIDEMIOLOGY AND PATHOPHYSIOLOGY
1 Epidemiology of Hypertension
2 Pathogenesis of Hypertension
SECTION II: DIAGNOSIS
3 Defining Hypertension
4 Office Blood Pressure Measurement
5 Home Monitoring of Blood Pressure
6 Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management
7 White Coat and Masked Hypertension
8 Secondary Hypertension: Renovascular Hypertension
9 Secondary Hypertension: Renin-Independent Mineralocorticoid Excess States
10 Secondary Hypertension: Pheochromocytoma
11 Secondary Hypertension: Sleep Apnea
12 Rare and Unusual Forms of Hypertension
SECTION III: RISK STRATIFICATION
13 The Natural History of Untreated Hypertension
14 The Special Problem of Isolated Systolic Hypertension
15 Assessment of Hypertensive Target Organ Damage
16 Prediction of Global Cardiovascular Risk in Hypertension
SECTION IV: TREATMENT
17 Diet and Blood Pressure
18 Diuretic Therapy in Cardiovascular Disease
19 ß-Blockers in Hypertension
20 Angiotensin-Converting Enzyme Inhibitors
21 Angiotensin Receptor Blockers
22 Calcium Channel Blockers in Hypertension
23 a-Blockers
24 New Drugs for Hypertension
25 Devices for Hypertension
SECTION V: OUTCOME STUDIES
26 Design of Outcomes Studies
27 Meta-Analyses of Hypertension Trials: The Blood Pressure Lowering Treatment Trialists’ Collaboration
SECTION VI: HYPERTENSION AND CONCOMITANT DISEASES
28 Ischemic Heart Disease in Hypertension
29 Heart Failure in Hypertension
30 Kidney Disease in Hypertension
31 Transplant Hypertension
32 Obesity in Hypertension
33 Peripheral Artery Disease in Hypertension
34 Cerebrovascular Disease in Hypertension
35 Hypertension and Diabetes Mellitus: An Update
36 Dyslipidemia in Hypertension
SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS
37 Hypertension in Pregnancy
38 Hypertension in Children and Adolescents
39 Hypertension in Older Patients
40 Hypertension in African Americans
41 Hypertension in Hispanics
42 Hypertension in East Asians and Native Hawaiians
43 Hypertension in South Asians
44 Resistant Hypertension
45 Hypertension and the Perioperative Period
46 Hypertensive Emergencies and Urgencies
SECTION VIII: HYPERTENSION TREATMENT IN THE FUTURE
47 Team-Based Care for the Management of Hypertension
48 Outcomes Research in Hypertension
49 Pharmacogenetics of Antihypertensive Treatment
50 Antihypertensive Drug Development: A Regulatory Perspective
SECTION IX: GUIDELINES
51 U.S. and Canadian Hypertension Guidelines
52 European and British Guidelines on Hypertension
Sei sicuro di voler eseguire questa azione?